Epicardial Adipose Tissue Thickness PredIcts Obstructive Coronary Artery Disease in Acute Coronary Syndrome Patients

Overview

Epicardial adipose tissue (EAT) is a visceral adipose tissue that surrounds the heart and the coronary arteries. It is metabolically active, secreting pro- and anti-inflammatory mediators and cytokines. With increasing EAT volume, inflammatory activity increasing, which suggests that EAT may locally influence atherosclerosis development in the coronary artery tree. The amount of EAT is associated with cardiovascular disease risk factors as well as presence and progression of subclinical atherosclerosis. Likewise, EAT volume is increased in patient with prevalent and incident coronary artery disease manifestation. In the setting of acute coronary syndrome, EAT was found to be associated with the TIMI risk score and Syntax II score. While CT imaging of the heart is the gold standard for EAT quantification, transthoracic echocardiography allows for a quick and reliable assessment of EAT thickness, as has been used in research studies and may qualify for routine EAT assessment in clinical routine.However, currently data on how quantification of EAT in clinical routine may impact patient management is lacking. We aim to investigate, whether quantification of EAT thickness via transthoracic echocardiography enables improved risk stratification in patients presenting with acute chest pain to the emergency department.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 14, 2020

Interventions

  • Diagnostic Test: Echocardiography
    • Assessment of epicardial adipose tissue thickness

Clinical Trial Outcome Measures

Primary Measures

  • Coronary revascularization
    • Time Frame: within 90 days after initial presentation
    • Number of Participants with need for coronary revascularization therapy

Secondary Measures

  • Invasive coronary angiography
    • Time Frame: within 90 days after initial presentation
    • Number of Participants undergoing invasive coronary angiography

Participating in This Clinical Trial

Inclusion Criteria

  • admission to the emergency department of the University Hospital Essen with acute chest pain suggestive of an acute coronary syndrome Exclusion Criteria:

  • Known obstructive coronary artery disease prior to presentation, prior revascularization therapy, unwillingness to provide informed consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Essen
  • Provider of Information About this Clinical Study
    • Principal Investigator: Amir Abbas Mahabadi, Principal Investigator – University Hospital, Essen
  • Overall Official(s)
    • Amir A Mahabadi, MD, Principal Investigator, University Hospital, Essen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.